Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary) ; Panitumumab (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 06 Apr 2011 New trial record